Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AKORN

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

ALEMBIC

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

ACIC PHARMS

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 27
  • 0 comments

FDA approve PANTOPRAZOLE SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • April 19, 2023, 11:42 UTC
  • 27
  • 0 comments

FDA approve KETAMINE HYDROCHLORIDE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • April 19, 2023, 11:42 UTC
  • 28
  • 0 comments

FDA approve METOPROLOL SUCCINATE

Comment Full text

SHANDONG

  • FDA Approval
  • April 18, 2023, 07:02 UTC
  • 28
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

SANDOZ INC

  • FDA Approval
  • April 17, 2023, 14:20 UTC
  • 29
  • 0 comments

FDA approve ADALIMUMAB-ADAZ

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 29
  • 0 comments

FDA approve PRAVASTATIN SODIUM

Comment Full text

SPIL

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 29
  • 0 comments

FDA approve METOPROLOL SUCCINATE

Comment Full text
  • Previous
  • 840
  • 841
  • 842
  • 843
  • 844
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5779)
  • SEC News(257800)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152339)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin